Bausch + Lomb (BLCO) Financial Analysis & Valuation | Quarter Chart
Bausch + Lomb (BLCO)
BLCOPrice: $16.63
Fair Value: 🔒
🔒score
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, in... more
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three seg... more
Description
Shares
| Market Cap | $5.93B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | CA | CEO | Brenton L. Saunders |
| IPO Date | 2022-05-06 | CAGR | 0.05% |
| Employees | 13,500 | Website | www.bausch.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.04% | Total Yield | 0.04% |
BLCO chart loading...
Fundamentals
Technicals
| Enterprise Value | $5.73B | P/E Ratio | 25.58 |
| Forward P/E | 14.79 | PEG Ratio | — |
| P/S Ratio | 1.2 | P/B Ratio | 0.98 |
| P/CF Ratio | 18.32 | P/FCF Ratio | 1445.16 |
| EPS | $0.65 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 7.85% | Gross Margin | 0.56% |
| Operating Margin | 0.06% | Profit Margin | -0.04% |
| ROE | -0.03% | ROA | -0.02% |
| ROCE | 0.03% | Current Ratio | 1.53 |
| Quick Ratio | 0.99 | Cash Ratio | 0.15 |
| Debt/Equity | 0.01 | Interest Coverage | 0.71 |
| Altman Z Score | 0.92 | Piotroski Score | 5 |